The Pro-Apoptotic Effect of Diallyl Trisulfide (DATS) on MDA-MB-231 Breast Cancer Cells
Article Sidebar
Main Article Content
Erla Syah Dilla Ailany
Lysa Veterini
Winawati Eka Putri
Diyan Wahyu Kurniasari
Abstract
Introduction: Breast cancer is the most prevalent cancer globally, impacting almost 2.1 million people each year. The MDA-MB-231 exemplifies the aggressive nature of the triple-negative breast cancer (TNBC) subtype. Diallyl Trisulfide (DATS) in Allium sativum (garlic) demonstrates potential anticancer characteristics primarily by causing the generation of ROS that may trigger apoptosis.
Objective: The study evaluates the effect of DATS on apoptosis in MDA-MB-231 cells via the ROS pathway.
Methods: An in vitro study utilizing MDA-MB-231 cells, categorized into four groups: (1) Medium control, (2) Negative control, (3) 20 µM DATS after 24 hours, and (4) 40 µM DATS after 24 hours. The study used Annexin V-FITC/PI flow cytometry to measure apoptotic cell death, the MTT assay to measure cell viability, and DCFH-DA fluorescence to measure ROS production.
Results: Cell viability was decreased after DATS treatment and a substantial increase in intracellular ROS production was observed that varies with time and dose (p < 0.001). In comparison to the other groups, the group that received 40 µM DATS for 24 hours had the highest rate of apoptosis and the largest accumulation of reactive oxygen species (ROS).
Conclusions: DATS significantly elevates intracellular ROS levels to promote apoptosis in MDA-MB-231 cells as a pro-oxidant therapy for aggressive breast cancer.
Downloads
Article Details
Copyright (c) 2025 Erla Syah Dilla Ailany, Lysa Veterini, Winawati Eka Putri, Diyan Wahyu Kurniasari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Chandra-Kuntal, K., Lee, J., & Singh, S. V. (2013). Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic. Breast Cancer Research and Treatment, 138(1), 69–79. https://doi.org/10.1007/s10549-013-2440-2 DOI: https://doi.org/10.1007/s10549-013-2440-2
De Gianni, E., & Fimognari, C. (2015). Anticancer Mechanism of Sulfur-Containing Compounds. Enzymes, 37, 167–192. https://doi.org/10.1016/bs.enz.2015.05.003 DOI: https://doi.org/10.1016/bs.enz.2015.05.003
Dinas Kesehatan Kota Surabaya. (2019). Profil Kesehatan Kota Surabaya.
Gan, R. Y., Zhang, J. J., Li, H. Bin, Meng, X., Li, S., & Li, Y. (2017). Dietary natural products for prevention and treatment of breast cancer. Nutrients, 9(7), 728. DOI: https://doi.org/10.3390/nu9070728
Kanga, K. J. W., Mendonca, P., Soliman, K. F. A., Ferguson, D. T., & Darling-Reed, S. F. (2021). Effect of diallyl trisulfide on TNF-α-induced CCL2/MCP-1 release in genetically different triple-negative breast cancer cells. Anticancer Research, 41(12), 5919–5933. https://doi.org/10.21873/anticanres.15411 DOI: https://doi.org/10.21873/anticanres.15411
Kemenkes RI. (2019). Penyakit Kanker di Indonesia Berada Pada Urutan 8 di Asia Tenggara dan Urutan 23 di Asia. Kemenkes RI. http://p2p.kemkes.go.id/penyakit-kanker-di-indonesia-berada-pada-urutan-8-di-asia-tenggara-dan-urutan-23-di-asia/
Kiesel, V. A., & Stan, S. D. (2017a). Diallyl trisulfide, a chemopreventive agent from Allium vegetables, inhibits alpha-secretases in breast cancer cells. Biochemical and Biophysical Research Communications, 484(4), 833–838. https://doi.org/10.1016/j.bbrc.2017.01.184
Kiesel, V. A., & Stan, S. D. (2017b). Diallyl trisulfide, a chemopreventive agent from Allium vegetables, inhibits alpha-secretases in breast cancer cells. Biochemical and Biophysical Research Communications, 484(4), 833–838. https://doi.org/10.1016/j.bbrc.2017.01.184 DOI: https://doi.org/10.1016/j.bbrc.2017.01.184
Kim, S.-H., Hahm, E.-R., Singh, K. B., & Singh, S. V. (2020). Diallyl Trisulfide Inhibits Leptin-induced Oncogenic Signaling in Human Breast Cancer Cells but Fails to Prevent Chemically-induced Luminal-type Cancer in Rats. Journal of Cancer Prevention, 25(1), 1–12. https://doi.org/10.15430/jcp.2020.25.1.1 DOI: https://doi.org/10.15430/JCP.2020.25.1.1
Liu, Y., Zhao, Y., Wei, Z., Tao, L., Sheng, X., Wang, S., Chen, J., Ruan, J., Liu, Z., Cao, Y., Shan, Y., Wang, A., Chen, W., & Lu, Y. (2018). Targeting thioredoxin system with an organosulfur compound, diallyl trisulfide (DATS), attenuates progression and metastasis of triple-negative breast cancer (TNBC). Cellular Physiology and Biochemistry, 50(5), 1945–1963. https://doi.org/10.1159/000494874 DOI: https://doi.org/10.1159/000494874
Liu, Y., Zhu, P., Wang, Y., Wei, Z., Tao, L., Zhu, Z., Sheng, X., Wang, S., Ruan, J., Liu, Z., Cao, Y., Shan, Y., Sun, L., Wang, A., Chen, W., & Lu, Y. (2015a). Antimetastatic therapies of the polysulfide diallyl trisulfide against triple-negative breast cancer (TNBC) via suppressing MMP2/9 by blocking NF-κB and ERK/MAPK signaling pathways. PLoS ONE, 10(4). https://doi.org/10.1371/journal.pone.0123781 DOI: https://doi.org/10.1371/journal.pone.0123781
Malla, R. R., Marni, R., Chakraborty, A., & Kamal, M. A. (2022). Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer. Journal of Pharmaceutical Analysis, 12(2), 221–231. https://doi.org/10.1016/j.jpha.2021.11.004 DOI: https://doi.org/10.1016/j.jpha.2021.11.004
Marni, R., Kundrapu, D. B., Chakraborti, A., & Malla, R. R. (2022). Insight into drug sensitizing effect of diallyl disulfide and diallyl trisulfide from Allium sativum L. on paclitaxel-resistant triple-negative breast cancer cells. Journal of Ethnopharmacology, 296. https://doi.org/10.1016/j.jep.2022.115452 DOI: https://doi.org/10.1016/j.jep.2022.115452
Na, H. K., Kim, E. H., Choi, M. A., Park, J. M., Kim, D. H., & Surh, Y. J. (2012). Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1. Biochemical Pharmacology, 84(10), 1241–1250. https://doi.org/10.1016/j.bcp.2012.08.024 DOI: https://doi.org/10.1016/j.bcp.2012.08.024
Puccinelli, M. T., & Stan, S. D. (2017). Dietary Bioactive Diallyl Trisulfide in Cancer Prevention and Treatment. International Journal of Molecular Sciences, 18(8), 1645. https://doi.org/10.3390/ijms18081645 DOI: https://doi.org/10.3390/ijms18081645
Riskesdas. (2013). Laporan Nasional Riskesdas 2013. Badan Penelitian Dan Pengembangan Kesehatan, 304. https://www.litbang.kemkes.go.id/laporan-riset-kesehatan-dasar-riskesdas/
Riskesdas. (2018). Laporan Nasional RISKESDAS 2018. In Badan Penelitian dan Pengembangan Kesehatan. Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan. http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf
Shigemi, Z., Furukawa, Y., Hosokawa, K., Minami, S., Matsuhiro, J., Nakata, S., Watanabe, T., Kagawa, H., Nakagawa, K., Takeda, H., & Fujimuro, M. (2016). Diallyl trisulfide induces apoptosis by suppressing NF-B signaling through destabilization of TRAF6 in primary effusion lymphoma. International Journal of Oncology, 48(1), 293–304. https://doi.org/10.3892/ijo.2015.3247 DOI: https://doi.org/10.3892/ijo.2015.3247
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660 DOI: https://doi.org/10.3322/caac.21660
WHO. (2020). Global cancer observatory. International agency for research on cancer.